Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0026 | 1 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0031 | 1 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |